SMAR is one of the few names not releasing earnings right now, and appears an attractive play.
I am not a precious metal trader, but I was drawn to SLV.
The small biotech's market cap sits at $125 million, the low end of what I believe is fair.
I'll show you how, step by step, to treat every holding as an income producer.
A spread or butterfly is off the table with the bid-ask spread, but despite the wide spreads, an in-the-money call may be the best bet.
One question I found particularly interesting revolved around the structure of the equity puts Berkshire Hathaway sold years ago during the financial crisis.
Consider this options trade as AAPL's strength seems overdone in this environment.
I think we could see the VIX make a run back to 45.
Keep this one near the top of your watchlist next week.
Think you're diversified? Understanding what you are investing and trading in is key.